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INTRODUCTION:  A  rare but  signiﬁcant  cause  for stroke  is  sub-intimal  carotid  dissection  and  this mech-
anism  accounts  for approximately  2.5%  of all strokes.1 Dissection  of the  carotid  artery  is often  caused
by  trauma  to  the  face  or neck.2 Under  45 years  old, it is  the  second  leading  cause  of  stroke.3 Neurologi-
cal  symptoms  can  be  lacking  or subtle,  therefore  the  condition  may  be  overlooked  but the  pathological
processed  is believed  to be attributed  to  thromboembolism.4 Microemboli  in  the  middle  cerebral  artery,
are  known  as  a risk  factor  for ischaemic  stroke  following  a transient  ischaemic  attack  (TIA)  and  can  be
detected  by  transcranial  Doppler  examination  (TCD).5 The  established  treatment  regime  is antiplatelet
therapy,  anticoagulation  or both  along  with  supportive  therapy.6 Current  evidence  suggests  managing
microemboli  in both  crescendo  TIA’s  and  post  carotid  endarterectomy  improves  outcome.7 We  haveranscranial Doppler
iroﬁban
arotid  artery
found  the  use  of  Tiroﬁban,  a potent  intravenous  antiplatelet  agent  currently  licensed  for  use  in acute
coronary  syndrome,  effective  in  the  treatment  of  microemboli  in this  manner.7
CASE  PRESENTATION:  We  report  a  case  of  symptomatic  carotid  artery  dissection  post  radical  neck  dissec-
tion,  causing  TCD  detected  microemboli  and  successfully  treated  with  Tiroﬁban.
CONCLUSION: We  believe  further  study  into  the  use  of  Tiroﬁban  in the  treatment  of microemboli  after
carotid  dissection  is  indicated.
gical  © 2011 Sur
. Case report
A  53 year old right handed man, non smoker presented 24 h post
ecurrent left radical neck dissection, permanent tracheostomy,
nd left pectoralis free ﬂap formation with a left hemisphere cere-
ral vascular accident. His initial operation performed 1 year prior
as for T2N0 squamous cell carcinoma of the left lateral tongue
as; left hemiglossectomy, selective neck dissection, left radical
orearm ﬂap with lip split and mandibulectomy. This was compli-
ated by infection at the mandible site, 7 days post op and required
 return to theatre for debridement.
The patient presented 1 year later with recurrent disease, requir-
ng further surgical intervention due to difﬁculty swallowing. He
nderwent further surgery which was complicated intraopera-
ively by signiﬁcant blood loss (3.5 l) requiring transfusion and
igation of the left external carotid artery. The patient’s initial recov-
ry although uneventful the following neurological signs present
ere noted; left pupil not reacting to light, with a right sided pto-
is. The patients’ limb movements and physiological parameters
ere normal.
However, on the ﬁrst post operative day, examination revealed
he patient had suffered a dense cerebral vascular accident (CVA)
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and was  moribund. Computerised tomography revealed 2 focal
infarcts, one within the left middle cerebral artery (MCA) territory
and the other at the anterior/middle cerebral artery watershed ter-
ritory (Figs. 1–3). A further left basal ganglia infarct was  noted. Due
to the patient’s inoperative blood loss aspirin was withheld. On the
second post operative day, after a period of observation the patient
underwent a carotid ultrasound. This demonstrated a normal com-
mon  carotid artery (CCA) but with high resistance, compatible with
a distal severe stenosis or occlusion. Only one ﬂow channel could
be visualised exiting the carotid bulb, but its exact anatomy was
unclear and further imaging was  required. Transcranial Doppler
interrogation of the left MCA  showed 15 microembolic signals in
10 min. After discussion between the vascular surgeons and the
maxillo-facial surgeons a decision to start a TCD directed intra-
venous anti-platelet agent was  made and Tiroﬁban was  started
as per protocol. A repeat vascular ultrasound (TCD) performed the
following day while the patient remained on Tiroﬁban and noted
a reduction in embolic load to 5 emboli in 15 min. A repeat scan
was performed post operative day 6 when Tiroﬁban was  stopped
and this did not demonstrate any microemboli. CT angiogram
performed the same day revealed a dissection of the left ICA at
its origin. Subsequently a further carotid Doppler no a TCD was
performed on post operative day 9 and this also conﬁrmed no
microemboli. The patient was  commenced on aspirin 75 mg  and
Open access under CC BY-NC-ND license.clopidogrel 75 mg and the Tiroﬁban discontinued. The patient
made a dramatic neurological improvement but still had mild
right-sided upper limb weakness on discharge, Warfarin was not
given.
C-ND license. 
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cig. 1. Computerised tomography demonstrating left sided cerebral infarct (arrow).
. Discussion
Internal carotid artery (ICA) dissection is rare but signiﬁcant,
ith an incidence that peaks in the ﬁfth decade and is equal in
oth sexes.8 It is estimated to occur in 2.6 cases per 100,0009 and
s responsible for 2% of all ischaemic strokes.8 When occurring in
he young <50 years of age it can account for 5–20% of strokes.10
Usually incidentally found and asymptomatic, the prevalence
f ischaemic events from ICA dissection can vary from 50 to
5%.11 Clinically sequelae can range from dense cerebrovascular
ig. 2. Ultrasound carotid Doppler demonstrating a difference in visualised intensity
f ﬂow (top = right side, bottom = left side). Abbreviations: RT ICA, right internal
arotid  artery; LT ICA, left internal carotid artery.Fig. 3. Computerised tomography angiogram demonstrating dissection of the left
internal carotid artery at its origin (arrow).
accidents (20–60%) to transient ischaemic events (9%–21%)12, but
most patients will have transitory events with 80% neurologi-
cal recovery.11 Therefore long term prognosis is favourable, with
recanalisation of the artery.13 Although the pathogenesis is unclear
thromboembolic events are implicated in 90% of infarcts, and an
association with reduced blood ﬂow rate has been postulated.1,4
The investigation of choice with carotid dissection is carotid
Doppler.14 This modality is a very sensitive tool for both the initial
diagnosis and long term follow up15 with an overall sensitivity of
95% with combined extracranial Doppler, transcranial Doppler, and
Duplex ultrasonography.14 In a small study by Alecu, detection rate
of carotid injury was  86% with ultrasound.16 Angiography and CT
although available to detect changes in vessel diameter and intra-
luminal haematoma respectively, both are considered unreliable
and lack sensitivity.11
The mainstay of treatment of ICA dissection is centred at
control of embolisation and prevention of thrombus propaga-
tion. Currently, the method of treatment is unclear but revolves
around the use of antiplatelet agents with or without the use of
anticoagulation.14 Miller and colleagues17, demonstrated the use
of early anticoagulation use may  perhaps reduce ischaemic events
while Ruiz et al. was able to demonstrate positive outcome with the
use of only antiplatelet agents.18 Failure of medical management
or disease progression resulting in unstable neurological symptoms
warrants surgical or endovascular intervention.
TCD monitoring detects haemodynamic changes within the
MCA and can demonstrate the presence of microembolic signals.
Srinivasan et al. found 59% of their 17 patients, after carotid dissec-
tion had microembolic signals. Seventy percent of their patients
with TCD detected microemboli had neurological deﬁcits.19 The
presence of microemboli is a signiﬁcant predictor of recurrent
events in TIA’s or CVA’s.8 Carotid dissection results in disruption
of the vessel wall resulting in an exposed thrombogenic surface
producing platelet aggregates known as microemboli. A similar
mechanism of microembolic production can be explained post
carotid endarterectomy.20 TCD directed Tiroﬁban therapy to con-
trol microemboli after carotid endarterectomy and in patients with
crescendo TIA is shown to be effective in preventing neurological
events.7 This treatment strategy was  employed for the patient in
this case report.This  case report illustrates the possibilities of TCD directed
anti-platelet interventions in very challenging clinical situations.
A surgical or endovascular intervention in a moribund hemiplegic
patient 48 h after complex re-do oncological surgery complicated
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y signiﬁcant blood loss is unlikely to be straightforward. The
isks of the Tiroﬁban infusion include failure to control the emboli
nd rebleeding. However the evidence from post carotid surgery
iroﬁban infusion for cerebral embolisation is that this risk is
ot excessive (van Dellen). TCD directed Tiroﬁban appears to
ave reduced then caused cessation of the microembolisation. The
eurological status of the patient subsequently improved as the
mbolic load reduced and the ICA recannulated. We  believe further
tudy into the use of Tiroﬁban in the treatment of microemboli after
arotid dissection is indicated.
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